Philadelphia MultiService Center, Philadelphia, PA

Philadelphia, Pennsylvania 19106

3 studies enrolling now · 8 studies all time

What they study most

BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, COVID-19, Cirrhosis, Colorectal Cancer, Depressive Disorder, Major, Metastatic Castrate Resistant Prostate Cancer, Opioid Use Disorder, Parkinson's Disease Psychosis, Physical Activity, RAD51B, RAD51C, RAD51D, or RAD54L Mutations

Studies at this site

• A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder — Recruiting now
• Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis — Recruiting now
• Carboplatin or Olaparib for BRcA Deficient Prostate Cancer — Recruiting now
• Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis — Running, not enrolling
• Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) — Running, not enrolling
• VA Aripiprazole vs Esketamine for Treatment Resistant Depression — Withdrawn before enrolling
• Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization — Completed
• Social and Financial Incentives to Increase Physical Activity Among Overweight and Obese Veterans — Completed